Literature DB >> 6805016

Amitriptyline and nortriptyline excretion in human breast milk.

L Brixen-Rasmussen, J Halgrener, A Jørgensen.   

Abstract

Simultaneous blood and milk samples were obtained from a 30-year-old woman who was on sustained release amitriptyline, and the concentrations of amitriptyline and the active metabolite, nortriptyline, were estimated by GLC. Serum and milk concentrations were similar with a slight tendency for the amitriptyline concentrations to be higher in milk. Calculation of the transfer of drug from the mother to the baby showed that the baby received an amitriptyline dose which was about one hundredth the dose given to the mother. No active drug could be estimated in the baby's serum and the baby showed no clinical signs which could be drug related.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805016     DOI: 10.1007/BF00430765

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  3 in total

1.  A gas chromatographic method for the determination of amitriptyline and nortriptyline in human serum.

Authors:  A Jorgensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-01

2.  Excretion of imipramine and desipramine in human breast milk.

Authors:  R Sovner; P J Orsulak
Journal:  Am J Psychiatry       Date:  1979-04       Impact factor: 18.112

3.  Amitriptyline in human breast milk and the nursing infant's serum.

Authors:  T F Bader; K Newman
Journal:  Am J Psychiatry       Date:  1980-07       Impact factor: 18.112

  3 in total
  15 in total

Review 1.  Antidepressants and breast-feeding: a review of the literature.

Authors:  S Dodd; A Buist; T R Norman
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 2.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

3.  Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients.

Authors:  I Matheson; J Skjaeraasen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  A guide to the safety of CNS-active agents during breastfeeding.

Authors:  C A Chisholm; J A Kuller
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

Review 5.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

6.  The excretion of dothiepin and its primary metabolites in breast milk.

Authors:  K F Ilett; T H Lebedevs; R E Wojnar-Horton; P Yapp; M J Roberts; L J Dusci; L P Hackett
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

Review 7.  Metabolism of tricyclic antidepressants.

Authors:  M V Rudorfer; W Z Potter
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

Review 8.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 9.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 10.  Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations.

Authors:  G Pons; E Rey; I Matheson
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.